Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous ketamine, pethidine, or metoclopramide for post-inguinal hernia repair pain
IRCT20150106020588N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ketamine, pethidine and metoclopramide in postoperative pain (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Pain intensity using visual analog scale. Started Apr 2018; status: completed.
02
Drugs
ketaminepethidinemetoclopramide
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20150106020588N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150106020588N7.